SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Cemtrex, Inc. engages in the provision of solutions in the technology industry. It operates through the following segments: Security, Industrial Services, and Cemtrex Corporate. The Security segment provides end-to-end security solutions to meet corporate, industrial, and governmental security challenges. The Industrial Services segment offers single-source expertise and services for rigging, millwrighting, in plant maintenance, equipment erection, relocation, and disassembly to diversified customers. The Cemtrex Corporate segment refers to the holding company of the other two segments. The company was founded on April 27, 1998 and is headquartered in Hauppauge, NY.

Cemtrex Inc.

Cemtrex ($CETX) is trending due to a massive premarket surge and multiple trading halts, sparking high volatility. Community chatter revolves around a potential short squeeze reminiscent of $SMX and predictions of continued upward momentum, with some suggesting extremely high price targets. The stock's nano float and recent acquisition news are also fueling the discussion.

Treasure Global, Inc. engages in the provision of payment solutions. The firm created an online-to-offline (O2O) e-commerce platform business model offering consumers and merchants instant rebates and affiliate cashback programs. It operates through the ZCITY Platform and Customized Software Development Service segments. The company was founded by Kok Pin Tan on March 20, 2020 and is headquartered in New York, NY.

Treasure Global Inc

Treasure Global (TGL) is trending due to a recent update to its 2026 revenue outlook, projecting significant growth through fintech and digital asset expansion, sparking interest in the stock's potential. Community discussions revolve around potential short squeezes and comparisons to other high-flying low float stocks like SMX. Traders are closely watching for trading halts and potential for after-hours momentum.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

VKTX is trending downwards as investors express disappointment, especially in comparison to GPCR's recent positive movement. The community is actively discussing concerns over VKTX's management and its ability to effectively communicate the potential of its drug, VK2735. Some investors speculate about a potential acquisition, while others urge a change in leadership to better capitalize on the company's assets.

SU Group Holdings Ltd. engages in the provision of security-related engineering services, and security guarding and screening services. It operates through the Security-Related Engineering Services and Security Guarding and Screening Services segments. The company was founded by Ming Chan in 1998 and is headquartered in Hong Kong.

SU Group Holdings Ltd. - Ordinary Shares - Class A

SU Group Holdings Ltd

SUGP is trending due to speculation of a potential short squeeze, drawing comparisons to recent low-float runners like $SMX and $TGL. The stock's low float and high short interest are fueling community discussions about a potential breakout, with traders actively monitoring price levels and anticipating a surge in volume. Some traders are expressing caution, citing past dilution and the stock's history, while others see significant upside potential.

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Wave Life Sciences Ltd.

Wave Life Sciences Ltd

Wave Life Sciences ($WVE) is trending following positive Phase 1 data for its obesity drug, WVE-007, which showed fat loss without muscle loss. The community is excited about the potential for infrequent dosing and is speculating about a possible offering or buyout. Discussions revolve around the significance of the data, potential price targets, and whether this is a Reddit-driven short squeeze.

Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its pipeline includes Aleniglipron GSBR-1290, ACCG-2671, GIPR, GCGR, ANPA-0073, and LTSE-2578. The company was founded by Raymond C. Stevens in 2016 and is headquartered in South San Francisco, CA.

Structure Therapeutics Inc - ADR

GPCR is trending following Phase 2 data highlighting weight loss percentages, though some investors are wary due to the omission of certain safety data in the initial report. The community is actively discussing the tolerability of the drug, particularly regarding liver enzyme elevations and adverse events like vomiting, while also speculating about potential short squeezes and comparisons to competitors like $LLY and $VKTX. Some see it as a potential acquisition target in the competitive GLP-1 space.

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

Carvana is trending due to its impending inclusion in the S&P 500, driving significant after-hours price movement. While some investors celebrate the milestone and anticipate further gains, others express concerns about the company's fundamentals and accounting practices, suggesting a potential "sell the news" event. Community discussions revolve around whether the stock is overvalued and if a substantial correction is on the horizon.

Warner Bros. Discovery, Inc. is a premier global media and entertainment company, which engages in the provision of a differentiated portfolio of content, brands, and franchises across television, film, streaming, and gaming. It operates through the following segments: Studios, Networks, Direct-to-Consumer (DTC), and Corporate. The Studios segment includes producing and releasing feature films for initial exhibition in theaters, producing and initial licensing television programs to networks services as well as third parties, distributing films and television programs to various third party, internal television, and streaming services, distribution through the home entertainment market related consumer products, and themed experience licensing and interactive gaming. The Networks segment focuses on domestic and international television networks. The DTC segment is involved in premium pay-television and streaming services. The company was founded on June 17, 1985 and is headquartered in New York, NY.

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

Warner Bros. Discovery ($WBD) is trending amid a potential takeover, with Paramount ($PARA) launching a hostile bid, challenging Netflix's ($NFLX) deal and igniting a bidding war. Community discussion revolves around the merits of each offer, regulatory hurdles, and potential outcomes for shareholders. The stock has seen significant gains YTD, fueled by M&A rumors and speculation.

PMGC Holdings, Inc. is a physician-dispensed skincare company, which engages in the research and development of skincare formulations. It is involved in the production and commercialization of topical skincare products that contain its proprietary stem cell-derived Elevai Exosomes. The company was founded by Hatem Abou-Sayed, Braeden William Lichti, and Jordan R. Plews on June 9, 2020 and is headquartered in Newport Beach, CA.

PMGC Holdings Inc

PMGC Holdings Inc.

ELAB is trending due to a premarket surge, fueled by retail trader interest in PMGC Holdings' shift towards biotech and industrial sectors. Community discussions revolve around the stock's low float and potential for a squeeze, while some traders are pointing to possible overextension. The stock's volatility and previous reverse splits are also being discussed.

Top Wealth Group Holding Ltd. operates as a holding company, which provides caviar and caviar-based gourmet products. It focuses on supplying sturgeon caviar to customers under its own brand, Imperial Cristal Caviar. The company was founded by Kim Kwan Kings Wong on February 1, 2023 and is headquartered in Hong Kong.

Top Wealth Group Holding Ltd. - Ordinary Shares - Class A

Top Wealth Group Holding Ltd.

TWG is trending due to its recent surge, fueled by a positive profit outlook for FY2025. Community discussions revolve around its low float, potential for further gains, and comparisons to other recent high-flying stocks like $TGL and $SMX. Some traders are wary, pointing to the stock's Hong Kong origins and the risk of pump-and-dump schemes.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shares of PMGC Holdings Inc. jumped 230% in early premarket trading on Tuesday, drawing significant interest from Stocktwits members.Message volume for the ticker on Stocktwits rose a whopping 7,400% in the last 24 hours, and the sentiment reading shifted to 'extremely bullish' as of early Tuesday from 'bullish' the previous day.There was no apparent catalyst for the stock, although several users said they had the ticker on their watchlist.&nbsp;<figure class="image"><img style="aspect-ratio:571/79;" src="https://news.stocktwits-cdn.com/Screenshot_2025_10_14_at_1_17_11_PM_png_0063eedc3a.webp" alt="Screenshot 2025-10-14 at 1.17.11 PM.png" width="571" height="79"><figcaption>ELAB sentiment and message volume as of October 14 | Source: Stocktwits</figcaption></figure>PMGC Holdings, which changed its name from Elevai Labs Inc. and also redomiciled from Delaware to Nevada in December 2024, is a U.S.-based holding firm. The company, through its subsidiaries, focuses on cutting-edge aesthetic medicines and therapeutic products for skin aesthetics, obesity, and metabolic health.Its main product, EL-22, is an engineered probiotic designed to help prevent muscle loss during weight loss treatments, such as those using GLP-1 drugs.So far this year, PMGC has approached at least two companies — one manufacturing high-precision parts for the aerospace and defense sectors, and another packing solutions firm — for acquisitions.In August, the company implemented a one-for-3.5 reverse stock split of its common stock.Year-to-date,&nbsp;<a href="https://stocktwits.com/symbol/ELAB">ELAB shares</a> are down 90.7% on a split-adjusted basis. The company had a market cap of $3.5 million as of the stock's last close.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/aka-stock-soars-over-40-after-hours/ch6mi41R3ls">AKA Stock Soars Over 40% After-Hours, Draws Interest From Retail Traders</a>

Traders work on the floor of the New York Stock Exchange during morning trading on September 17, 2025, in New York City. 

PMGC Holdings Stock Jumps 230% Premarket, Grabs Retail Eyeballs

Earlier known as Elevai Labs, PMGC turned into a holding company last year.

Equity

Earlier known as Elevai Labs, PMGC turned into a holding company last year.


Shares of PMGC Holdings Inc. (ELAB) surged over 25% on Monday morning after the company inked a non-binding letter of intent to acquire a U.S. electronics contract manufacturing firm with a four-decade operational track record.This marks PMGC’s second acquisition initiative since April. The agreement pertains to a privately held firm specializing in high-accuracy electronics manufacturing.&nbsp;The target company’s capabilities include assembling electrical and mechanical components, producing printed circuit boards, conducting electronic component evaluations, and offering prototyping services.&nbsp;In 2024, the target company reported approximately $699,000 in revenue and an adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) of around $173,000.With this latest step, PMGC aims to expand its holdings by acquiring financially sound enterprises recognized for their reliable earnings and growth potential.&nbsp;PMGC executives noted that the acquisition target is distinguished by its efficient operations and long-standing partnerships within the commercial and industrial electronics markets.This acquisition aligns with a broader resurgence in U.S.-based manufacturing, fueled by government initiatives like the CHIPS and Science Act.&nbsp;Enacted on Aug. 9, 2022, the bipartisan CHIPS and Science Act seeks to revitalize the U.S. semiconductor sector while strengthening the country’s research and innovation ecosystem.&nbsp;The legislation allocates $52.7 billion in federal support to initiatives such as building new chip fabrication plants, advancing research and development efforts, and enhancing workforce training.&nbsp;As more supply chains shift back to domestic production, demand for American electronics manufacturers is on the rise.PMGC views this transaction as a timely opportunity to tap into that growing momentum.On Stocktwits, retail sentiment around PMGC changed to ‘extremely bullish’ from ‘bearish’ the previous day.<figure class="image"><img style="aspect-ratio:958/104;" src="https://news.stocktwits-cdn.com/Screenshot_2025_06_09_102350_png_3369427ecd.webp" alt="PMGC's Sentiment Meter and Message Volume as of 10:40 a.m. ET on Jun. 9, 2025 | Source: Stocktwits" width="958" height="104"><figcaption>PMGC's Sentiment Meter and Message Volume as of 10:40 a.m. ET on Jun. 9, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user expressed optimism on the shares.<stembedurl>https://stocktwits.com/cjstocksup/message/617252666</stembedurl> <a href="https://stocktwits.com/symbol/ELAB">PMGC</a> stock has lost over 82% in 2025 and over 99% in the last 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/leddar-tech-extends-credit-and-loan-terms-welcomes-back-employees/chlEWXwRby9">LeddarTech Stock Jumps As Company Announces Amended Loan Terms: Retail Stays On The Sidelines</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

PMGC Stock Rockets After Acquiring US Electronics Firm: Retail Ramps Up Exposure

PMGC views the transaction as a timely opportunity, as demand for American electronics manufacturers is on the rise, with more supply chains shifting back to domestic production.

Shares of PMGC Holdings Inc. (Elab) surged more than 50% on Friday as the skin care and biopharma products company said its subsidiary plans to present a probiotic-based weight loss treatment, sparking retail chatter.PMGC, formerly Elevai Labs, said its subsidiary Northstrive Biosciences was invited to present at an upcoming symposium called Anti-Obesity Treatments: Challenges and Emerging Solutions organized by UCLA Metabolism Theme, the company said.This symposium is targeted at obesity-focused clinicians, researchers, drug developers and investors to address the challenges brought up by weight loss treatments.Northstrive Biosciences’ EL-22 product is a probiotic approach for preserving muscle while on weight loss treatments, said the company. Northstrive’s EL-22 is being developed as a potential combination therapy with GLP-1 receptor agonists for preserving muscle while on weight loss treatments. According to studies, about 30-50% of body weight lost with GLP-1 based therapy is lean muscle mass, a common side effect.<stembedurl>https://stocktwits.com/DumbMoneyDoji/message/601529726</stembedurl><stembedurl>https://stocktwits.com/Schizoo/message/601513712</stembedurl>“The rise of anti-obesity medications has put the spotlight on the challenges being faced, particularly the management of muscle and bone loss associated with GLP-1 receptor agonists,” Orian Shirihai, Director of UCLA’s Metabolism Theme, said. “We organized this event to gather obesity’s leading opinion leaders to review the gaps and highlight the emerging solutions.”Last month, PMGC underwent a ‘strategic reorganization’ that included a name change to PMGC Holdings and redomiciling from Delaware to Nevada, in an effort to ‘streamline operations and create a more efficient legal and governance framework.”PMGC specializes in medical aesthetics and biopharmaceuticals with its subsidiaries across skincare, biosciences, research, among others.PMGC stock is up 35% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Representative image. Source: Getty Images

PMGC Stock Surges On Invitation To Present ‘Probiotic’ For Preventing Muscle Loss: Retail Chatter Spikes

Its product, EL-22, is a probiotic approach for preserving muscle while on weight loss treatments

Shares of Elevai Labs Inc. ($ELAB) rose 8% on Friday after the operator of skin care product companies announced a ‘strategic reorganization’ including a name change to PMGC Holdings and redomiciling from Delaware to Nevada, drawing a mixed reaction from retail investors on Stocktwits. After this reorganization, Elevai, which specializes in medical aesthetics and biopharmaceuticals, will continue to trade on The Nasdaq Stock Market under the ticker symbol “ELAB.” The redomestication and name change will go into effect on Nasdaq at the opening of business on December 23, the company said.According to a company statement, the company will focus on enhancing operational efficiencies across its existing entities and pursue ‘synergistic acquisitions’ and also consider ‘strategic divestitures’ of assets that are underperforming or do not align with its long-term strategy. Its decision to redomicile from Delaware to Nevada aligns with its “mission to streamline operations and create a more efficient legal and governance framework,” it added, noting legal benefits such as a business-friendly regulatory environment and potential for long-term cost savings as a result of lower state tax obligations.Retail rection on Stocktwits was a mixed bag.<stembedurl>https://stocktwits.com/CatchingCrumbs/message/597432218</stembedurl><stembedurl>https://stocktwits.com/Chester_Copperpot85/message/597445584</stembedurl>Elavai’s portfolio consists of four wholly owned subsidiaries: Elevai Skincare Inc., Elevai Biosciences Inc., Elevai Research Inc., and PMGC Capital LLC.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Elevai Labs Announces Name Change to PMGC Holdings: Retail’s Cautious

After this reorganization, Elevai will continue to trade on The Nasdaq Stock Market under the ticker symbol “ELAB.”

The S&amp;P 500 retreated from its closing high (6,001.35) hit on Monday before ending the week at 5,870.62, down 2.08% for the 5-session period. Techs suffered steep losses, as evident from the 3.15% pullback by the Nasdaq Composite Index. The 30-stock Dow Jones Industrial Average was down a more modest 1.24%.As the rally stalled and the broader market experienced its steepest weekly losses since early September, the following stocks were the most active on the Stocktwits platform (based on message volume):<ul><li>Dogecoin (<a class="mention" data-mention="$DOGE.X" data-symbol-id="DOGE.X" href="https://stocktwits.com/symbol/DOGE.X" target="_blank">$DOGE.X</a>)</li><li>Bitcoin (<a class="mention" data-mention="$BTC.X" data-symbol-id="BTC.X" href="https://stocktwits.com/symbol/BTC.X" target="_blank">$BTC.X</a>)</li><li>Tesla, Inc. (<a class="mention" data-mention="$TSLA" data-symbol-id="TSLA" href="https://stocktwits.com/symbol/TSLA" target="_blank">$TSLA</a>)</li><li>Super Micro Computer, Inc. (<a class="mention" data-mention="$SMCI" data-symbol-id="SMCI" href="https://stocktwits.com/symbol/SMCI" target="_blank">$SMCI</a>)</li><li>Ripple (<a class="mention" data-mention="$XRP.X" data-symbol-id="XRP.X" href="https://stocktwits.com/symbol/XRP.X" target="_blank">$XRP.X</a>)</li><li>SPDR S&amp;P 500 ETF Trust (<a class="mention" data-mention="$SPY" data-symbol-id="SPY" href="https://stocktwits.com/symbol/SPY" target="_blank">$SPY</a>)</li><li>Autozi Internet Technology Global Ltd. (<a class="mention" data-mention="$AZI" data-symbol-id="AZI" href="https://stocktwits.com/symbol/AZI" target="_blank">$AZI</a>)</li><li>Trump Media &amp; Technology Group Corp. (<a class="mention" data-mention="$DJT" data-symbol-id="DJT" href="https://stocktwits.com/symbol/DJT" target="_blank">$DJT</a>)</li><li>GameStop Corp. (<a class="mention" data-mention="$GME" data-symbol-id="GME" href="https://stocktwits.com/symbol/GME" target="_blank">$GME</a>)</li><li>Elevai Labs, Inc. (<a class="mention" data-mention="$ELAB" data-symbol-id="ELAB" href="https://stocktwits.com/symbol/ELAB" target="_blank">$ELAB</a>)</li></ul>Dogecoin: Riding on the crypto rally following Donald Trump’s victory in the 2024 presidential election, Dogecoin rallied to a high of $0.435863 on Tuesday pulling back to a low of $0.354469 three sessions later.&nbsp;A poll&nbsp; to solicit opinion from Stocktwits users regarding the year-end price target for Doge, which has an hour left for closing, showed about 41% think it would end 2024 between $0.50 and $1.00.&nbsp;A Stocktwits user said the rally could resume if rumors of the incoming Trump administration eliminate capital gains taxes on U.S.-issued cryptocurrencies.&nbsp;<stembedurl>https://stocktwits.com/Gainz4dayss/message/592967020</stembedurl>Bitcoin:&nbsp;Bitcoin, which is the top crypto by market capitalization, broke above $80K last Sunday and climbed to an intraday high of $93,434.35 on Wednesday. Since then, the Bitcoin rally has cooled off amid the stock market weakness.&nbsp;Bullish investors and analysts are eyeing a break above the $100,000 mark.&nbsp;Stocktwits users are mostly positive, with one user suggesting the technical chart looks “pretty solid.”<stembedurl>https://stocktwits.com/MainlyAlright/message/592966996</stembedurl>Tesla:&nbsp;The extended rally in the shares of Elon Musk-led electric-vehicle company Tesla stalled last week. After scaling an intraday high of $358.64 and a closing high of $350 on Monday, the stock has pulled back sharply. For the week, Tesla shares lost 0.16%, although they shed a steeper 10.57% from the intraday highs.&nbsp;Tesla bull and the Future Fund LLC Managing Partner Gary Black recently trimmed his Tesla position, reasoning that Tesla at $350 is less attractive than Tesla at $140.Super Micro: Embattled artificial intelligence server maker Super Micro fell in the first four sessions of the week amid fears of potential delisting. The company delayed the filing of its annual report for the fiscal year 2024 and also its first quarter of the next fiscal that ended on Sept. 30, 2024.&nbsp;The company received some good tidings late in the week when three broker-dealers with common ownership acquired 30.83 million shares of the company, translating to a 5.3% stake.The unfolding week is important as investors await word on the company’s response to the deadline for filing its annual report.Ripple: Payments cryptocurrency XRP crossed the $1 threshold on Saturday for the first time in three years. The crypto’s strength is attributable to the expectations that the incoming Trump administration will formulate pro-crypto policies.&nbsp;Ripple has been the subject of an investigation by the SEC after the blockchain company raised more than $1.3 billion in 2013 by selling XRP in an unregistered public offering. The SEC has an ongoing lawsuit against Ripple in the U.S.&nbsp;Southern District Court of New York.The widespread expectation is that SEC Chair Gary Gensler, who has been tough with cryptocurrency companies, could step down soon as part of the new guard taking over on the political arena.&nbsp;SPY:&nbsp;Following the market pullback, SPY garnered some attention and was among the active sought out security on Stocktwits last week. The upcoming week is crucial for the SPY, as Nvidia - a heavily weighted stock, is scheduled to report earnings. The artificial intelligence stalwart’s earnings have ramifications for a slew of heavily-weighted tech stocks pursuing AI.&nbsp;Some key economic data due for the unfolding week include S&amp;P Global’s private sector activity readings for November, the Conference Board’s leading economic index for October, the weekly jobless claims data and a few housing market readings. The market participants may also stay tuned to a spate of Fed speeches scheduled for they week as they worry about the rate trajectory.Autozi:&nbsp;Chinese automotive products and services company Autozi was in the news last week amid news of increased institutional interest in the company. Message volume for the stock spiked higher, with most on Stocktwits ‘bullish’ on the stock.&nbsp;The company followed up with the two 13G filings on Wednesday, and filed yet another on Friday in which it disclosed CEO&nbsp;Houqi Zhang has hiked his stake to 40.6% of the Class A shares, assuming conversion of the Class B ordinary shares owned by him.&nbsp;Trump Media: The post-election bump received by Trump-controlled Trump Media &amp; Technology stock cooled off last week. The owner of Truth Social platform continues to be viewed positively by the retail.&nbsp;GameStop:&nbsp;Meme stock GameStop, a retailer of video games, saw volatility in the week ended Nov. 15. It, however, bucked the broader market weakness and ended the week up by 6.87%.&nbsp;Elevai Labs:&nbsp;Newport Beach, California-based Elevai, a skincare development company, was in the news over the release of its fiscal year second-quarter results last week. Retailers on Stockwits are hoping for a short-squeeze, with 19.08% of the outstanding shares held short.&nbsp;Read Next: <a href="https://stocktwits.com/news-articles/markets/equity/trip.com-earnings-for-q3-2024-due-after-the-market-close-monday/cJ4HsezRQ2">Trip.com Analysts Optimistic Amid Robust Travel Trends In China As Stock Looks To Extend Strong Gains For Year</a>For updates and corrections email newsroom@stocktwits.com&nbsp;

The broader market pulled back last week amid a few strong data and hawkish Fed commentary. | Photo Courtesy of Wikimedia Commons

10 Most Active Stocks On Stocktwits Last Week With Message Volume Spurt 

Cryptocurrencies, stocks that pulled back from their post-election highs, and some obscure securities were among those that saw huge message volumes in the past week.

Dow Gains Over 50 Points; Elevai Labs Shares Plummet

ELEVAI Labs Shares Future Direction and Financial Outlook

ELEVAI Labs Inc. (ELAB) has shared an announcement.

Elevai Labs Inc. has initiated the distribution of a key presentation to the investment community, showcasing a summary of their direction and...

Elevai Labs reports Q4 revenue $698,591 vs. $554,654 in Q3

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Elevai Labs reports Q4 results

Elevai Labs Inc. Reports Record Full Year 2023 and Fourth Quarter Financial Results

Company reports record annual revenues of $1.71 Million for 2023, up 123.5% over the previous year Company reports record Q4 2023 revenues of $698,591, up 403% from Q4 2022 NEWPORT BEACH, Calif...

ELAB
PMGC Holdings Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest ELAB News

ELABPMGC Holdings Inc.